Protective effect of the immunomodulator AS101 against cyclophosphamide- induced testicular damage in mice

Human Reproduction

Volumn 24, Issue 6, 2009, Pages 1322-1329

  Carmely, A ^a   Meirow, D ^b   Peretz, A ^a   Albeck, M ^a   Bartoov, B ^a   Sredni, B ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

AS101; Chemotherapy; Fertility preservation; Sperm DNA damage; Testicular damage

Indexed keywords

AMMONIUM TRICHLORO(DIOXYETHYLENE O,O')TELLURATE; CYCLOPHOSPHAMIDE; DNA; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHROMATIN; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DRUG EFFECT; ENZYME PHOSPHORYLATION; EPIDIDYMIS; HISTOPATHOLOGY; IMMUNOMODULATION; MALE; MALE FERTILITY; MALE INFERTILITY; MOUSE; NONHUMAN; ORGAN WEIGHT; SEMINIFEROUS TUBULE; SPERM; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; TESTIS INJURY;

ANIMALIA; MUS;

EID: 66249100523     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den481     Document Type: Article

References (38)

1. Agarwal A, Allamaneni SS. Disruption of spermatogenesis by the cancer disease process. J Natl Cancer Inst Monogr 2005;34:9-12.
2. Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update 2001 ;7:394-403.
3. Brodsky M, Yosef S, Galit R, Albeck M, Longo DL, Albeck A, Sredni B. The synthetic tellurium compound, AS 101, is a novel inhibitor of IL-1b converting enzyme. J Interferon Cytokine Res 2007;27:453-462.
4. Codrington AM, Hales BF, Robaire B. Spermiogenic germ cell phase-specific DNA damage following cyclophosphamide exposure. J Androl 2004;25:354-362.
5. Codrington AM, Hales BF, Robaire B. Exposure of male rats to cyclophosphamide alters the chromatin structure and basic proteome in spermatozoa. Hum Reprod 2007;22:1431 -1442.
6. Elangovan N, Chiou TJ, Tzeng WF, Chu ST. Cyclophosphamide treatment causes impairment of sperm and its fertilizing ability in mice. Toxicology 2006;222:60-70.
7. Evenson DP, Wixon R. Clinical aspects of sperm DNA fragmentation detection and male infertility. Theriogenology 2006;65:979-991.
8. Evenson DP, Larson KL, Jost LK. Sperm chromatin structure assay: its clinical use for detecting sperm DNA fragmentation in male infertility and comparisons with other techniques. J Androl 2002;23:25-43.
9. Garolla A, Pizzato C, Ferlin A, Carli MO, Selice R, Foresta C. Progress in the development of childhood cancer therapy. Reprod Toxicol 2006; 22:126-132.
10. Guo TB, Chan KC, Hakovirta H, Xiao Y, Toppari J, Mitchell AP, Salameh WA. Evidence for a role of glycogen synthase kinase-3 beta in rodent spermatogenesis. J Androl 2003;24:332-342.
11. Hayun M, Naor Y, Weil M, Albeck M, Peled A, Don J, Haran-Ghera N, Sredni B. The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway. Biochem Pharmacol 2006;72:1423-1431.
12. Howell SJ, Shalet SM. Testicular function following chemotherapy. Hum Reprod Update 2001 ;7:363-369.
13. Kalechman Y, Albeck M, Oron M, Sobelman D, Gurwith M, Horwith G, Kirsch T, Maida B, Sehgal SN, Sredni B. Protective and restorative role of AS 101 in combination with chemotherapy. Cancer Res 1991; 51:1499-1503.
14. Kalechman Y, Sotnik-Barkai I, Albeck M, Sredni B. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro (dioxyethylene-O-O')tellurate (AS101). Cancer Res 1993a;53:1838- 1844.
15. Kalechman Y, Shani A, Albeck M, Sotnik BI, Sredni B. Increased DNA repair ability after irradiation following treatment with the immunomodulator AS 101. Radiat Res 1993b; 1 36:197-204.
16. Kalechman Y, Shani A, Albeck M, Sredni B. Induction of acute phase proteins in mice and humans by treatment with AS 101, an immunomodulator with radioprotective properties. Immunopharmacology 1995a;29:149-158.
17. Kalechman Y, Zuloff A, Albeck M, Strassmann G, Sredni B. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-O-O')tellurate. Blood 1995b;85:1555-1561.
18. Kalechman Y, Longo DL, Catane R, Shani A, Albeck M, Sredni B. Synergistic anti-tumoral effect of paclitaxel (Taxol)pAS101 in a murine model of B16 melanoma: association with ras-dependent signal-transduction pathways. Int J Cancer 2000;86:281 -288.
19. Kalechman Y, Sredni B, Weinstein T, Freidkin I, Tobar A, Albeck M, Gafter U. Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS 101. J Am Soc Nephrol 2003; 14:620-630.
20. Kao GD, Jiang Z, Fernandes AM, Gupta AK, Maity A. Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation. J Biol Chem 2007; 282:21206-21212.
21. Lee J, Kanatsu-Shinohara M, Inoue K, Ogonuki N, Miki H, Toyokuni S, Kimura T, Nakano T, Ogura A, Shinohara T. Akt mediates self-renewal division of mouse spermatogonial stem cells. Development 2007; 134:1853-1859.
22. Makarovsky D, Kalechman Y, Sonino T, Freidkin I, Teitz S, Albeck M, Weil M, Geffen-Aricha R, Yadid G, Sredni B. Tellurium compound AS101 induces PC 12 differentiation and rescues the neurons from apoptotic death. Ann N Y Acad Sci 2003; 1010:659-666.
23. Meirow D, Schenker JG. Cancer and male infertility. Hum Reprod 1995; 10:2017-2022.
24. Meirow D, Lewis H, Nugent D, Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 1999; 14:1903-1907.
25. Okun E, Arumugam TV, Tang SC, Gleichmann M, Albeck M, Sredni B, Mattson MP. The organotellurium compound ammonium trichloro(dioxoethylene-O,O') tellurate enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice. J Neurochem 2007; 102:1232-1241.
26. ! Rao JN, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics 1992;48:577-585.
27. Rasoulpour T, DiPalma K, Kolvek B, Hixon M. Akt 1 suppresses radiation-induced germ cell apoptosis in vivo. Endocrinology 2006; 147:4213-4221.
28. Revel A, Haimov-Kochman R, Porat A, Lewin A, Simon A, Laufer N, Gino H, Meirow D. In vitro fertilization-intracytoplasmic sperm injection success rates with cryopreserved sperm from patients with malignant disease. Fertil Steril 2005;84:1 18-122.
29. Schover LR. Motivation for parenthood after cancer: a review. J Natl Cancer Inst Monogr 2005;34:2-5.
30. Sinuani I, Averbukh Z, Gitelman I, Rapoport MJ, Sandbank J, Albeck M, Sredni B, Weissgarten J. Mesangial cells initiate compensatory renal tubular hypertrophy via IL-10-induced TGF-b secretion: effect of the immunomodulator AS 101 on this process. Am J Physiol Renal Physiol 2006;291:F384- F394.
31. Sredni B, Caspi RR, Klein A, Kalechman Y, Danziger Y, Ben YM, Tamari T, Shalit F, Albeck M. A new immunomodulating compound (AS-101) with potential therapeutic application. Nature 1987;330:173-176.
32. Sredni B, Albeck M, Tichler T, Shani A, Shapira J, Bruderman I, Catane R, Kaufman B, Kalechman Y. Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide. J Clin Oncol 1995; 13:2342-2353.
33. Sredni B, Xu RH, Albeck M, Gafter U, Gal R, Shani A, Tichler T, Shapira J, Bruderman I, Catane R et al. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models. Int J Cancer 1996a;65:97-103.
34. Sredni B, Tichler T, Shani A, Catane R, Kaufman B, Strassmann G, Albeck M, Kalechman Y. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101. J Natl Cancer Inst 1996b;88:1276- 1284.
35. Sredni B, Gal R, Cohen IJ, Dazard JE, Givol D, Gafter U, Motro B, Eliyahu S, Albeck M, Lander HM et al. Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression. FASEBJ 2004a; 18:400-402.
36. Sredni B, Weil M, Khomenok G, Lebenthal I, Teitz S, Mardor Y, Ram Z, Orenstein A, Kershenovich A, Michowiz S et al. Ammonium trichloro(dioxoethylene- o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop. Cancer Res 2004b;64:1843- 1852.
37. Sredni B, Geffen-Aricha R, Duan W, Albeck M, Shalit F, Lander HM, Kinor N, Sagi O, Albeck A, Yosef S et al. Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models. FASEBJ 2007;21:1870-1883.
38. Tempest HG, Ko E, Chan P, Robaire B, Rademaker A, Martin RH. Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin's lymphoma patients. Hum Reprod 2008;23:251- 258.